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Background: Hydrogen/deuterium exchange (HDX) coupled to mass spectrometry permits analysis of structure,
dynamics, and molecular interactions of proteins. HDX mass spectrometry is confounded by deuterium
exchange-associated peaks overlapping with peaks of heavy, natural abundance isotopes, such as carbon-13.
Recent studies demonstrated that high-performance mass spectrometers could resolve isotopic fine structure and
eliminate this peak overlap, allowing direct detection and quantification of deuterium incorporation.
Results: Here, we present a graphical tool that allows for a rapid and automated estimation of deuterium
incorporation from a spectrum with isotopic fine structure. Given a peptide sequence (or elemental formula) and
charge state, the mass-to-charge ratios of deuterium-associated peaks of the specified ion is determined. Intensities
of peaks in an experimental mass spectrum within bins corresponding to these values are used to determine the
distribution of deuterium incorporated. A theoretical spectrum can then be calculated based on the estimated
distribution of deuterium exchange to confirm interpretation of the spectrum. Deuterium incorporation can also
be detected for ion signals without a priori specification of an elemental formula, permitting detection of exchange
in complex samples of unidentified material such as natural organic matter. A tool is also incorporated into
QUDeX-MS to help in assigning ion signals from peptides arising from enzymatic digestion of proteins.
MATLAB-deployable and standalone versions are available for academic use at qudex-ms.sourceforge.net and
agarlabs.com.
Conclusion: Isotopic fine structure HDX-MS offers the potential to increase sequence coverage of proteins being
analyzed through mass accuracy and deconvolution of overlapping ion signals. As previously demonstrated,
however, the data analysis workflow for HDX-MS data with resolved isotopic fine structure is distinct. QUDeX-MS
we hope will aid in the adoption of isotopic fine structure HDX-MS by providing an intuitive workflow and interface
for data analysis.
Keywords: Hydrogen/deuterium exchange, Isotopic fine structure, Fourier transform ion cyclotron resonance,
Mass spectrometry, Protein structure, Protein analysisBackground
Incubation of molecules in deuterium oxide and meas-
urement of exchange between hydrogen and deuterium
(i.e. hydrogen/deuterium exchange, abbreviated as HDX)
is a versatile technique for characterizing molecular struc-
ture and reactivity. Coupled with mass spectrometry
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range of analytical applications including studying folding/
unfolding [1-3] and oligomerization [4-8]; how mutation
[9-12], posttranslational modification [13-17], and inter-
action with other molecules affect protein structures
[18-25]; and the quality of biopharmaceuticals [26-28]. In
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Figure 1 Resolving power and acquisition time required to
observe deuterium-associated isotopic fine structure is charge
state dependent. A. In order to resolve deuterium-associated peaks,
it is necessary to detect a mass difference mHDX of ~2.922 mDa,
where mHDX is the mass difference between
2H and 1H minus the mass
difference between 13C and 12C. Increasing charge states require higher
resolving power at a given m/z. Plotted are the resolving powers
(m/Δm50% where Δm50% is the full width at half-maximum peak height)
required to observe deuterium-associated isotopic fine structure for
z= 1, 2, and 3 (Eq. 2). Δm50% was calculated assuming two peaks
separated by mHDX/z of equal height and Lorentzian peak shape are
resolved with a valley between them reaches half-maximum height for
either peak (Eq. 3). Also plotted (in black diamonds) are the resolving
powers required to observed various peptide ions we previously
monitored in a HDX experiment [9] to help illustrate the range of
resolving powers necessary for one representative set of data. B.
Theoretical minimum acquisition time required in order to resolve
deuterium-associated isotopic fine structure as a function of absolute
mass for various charge states. For a 9.4 T FTICR-MS operating in
absorption mode, we assumed a conservative ~1.45-fold improvement
in resolving power over the magnitude mode low-pressure limit
(Eq. 1, effective field B0 = 13.6 T [47]). For the 12 T FTICR-MS operating
in absorption mode, we assumed the maximum 2-fold improvement
in resolving power over the magnitude mode low-pressure limit, which
can be valid for acquisition times of less than a few seconds [46,47].
Again plotted (in black diamonds) are peptide ions monitored from an
actual HDX experiment [9] to help illustrate the range of acquisition
times that would be necessary without further optimization.
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http://www.biomedcentral.com/1471-2105/15/403HDX MS consumes far less sample, requires lower con-
centrations, and can analyze larger protein complexes. In
a typical HDX MS workflow examining protein structure,
proteins are labeled with deuterium oxide around physio-
logical pH for a range of periods of time (from seconds to
days), followed by a reaction quenching including a drop
to acidic pH (~2.5) and lowered temperature (0?C) [29].
To map deuterium incorporation, and in turn, map extent
of solvent exposure of residues, a bottom-up strategy is
often adopted whereby proteases (capable of digesting
proteins under the acidic quench conditions) break down
proteins prior to MS analysis. MS analysis is often perfor-
med by electrospray ionization (ESI), although matrix-
assisted laser desorption/ionization (MALDI) can also
be beneficial [30,31]. Liquid chromatography (LC) is
often utilized prior to MS to separate digest peptides
and increase protein coverage. A number of computational
utilities have been introduced to streamline the analysis of
HDX MS data, including HDX-Analyzer [32], HX-Express
[33], Deuterator [34], HD Desktop [35], DEX [36], Hydra
[37], TOF2H [38], and Hexicon [39,40].
One caveat of HDX MS data analysis is that at typical
resolving powers (including relatively high resolving pow-
ers routinely obtained on FT-Orbitrap instruments), pep-
tide deuteration is detected as a convolution of deuterated
peaks with peaks corresponding to the natural abundance
distribution of heavy isotopes (i.e. 13C, 15 N, 18O, and 34S/
36S). Thus, in order to estimate the distribution of deuter-
ium incorporation, typical HDX analysis determines the
mass centroid shift between the deuterated and the native
isotope pattern of a peptide to measure average deuterium
incorporation. Methods for estimating the full distri-
bution of deuterium exchange, to detect potential bi-
modal exchange behaviors, have also be devised [39,40],
although these methods are dependent upon sequence in-
formation and/or the undeuterated isotope distribution.
To minimize back-exchange during chromatography, fast
gradients are necessary, increasing the potential for over-
lapping peak distributions in spectra. High mass reso-
lution can help to alleviate this problem, and algorithms
have been developed to estimate accurate deuterium
content in spectra with overlapping distributions at
low signal-to-noise [41]. At sufficiently high resolving
powers (m/Δm50% ≥ 100,000), elemental compositions
of peptides can be used to reliably assign overlapping
distributions in a rapid and automated procedure [42].
However, as resolving power increases, the mass defect
associated with different atomic nuclei binding energies
leads to the detection to the isotopic fine structure. In-
deed, at ultrahigh resolving powers (Figure 1A) deuterium
exchange-associated peaks become distinct from natural
abundance heavy isotopic species, enabling a more
direct detection of the distribution of deuterium incorp-
oration [43].
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(FTICR) mass spectrometers operating at low-pressure,
resolving power m/Δm50% (where Δm50% is the full width
at half-maximum peak height) at a particular m/z is lim-
ited in magnitude mode by the strength of the magnetic
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While long acquisition periods can be used to produce
spectra of sufficient quality to resolve deuterium exchange-
associated peaks, limiting the acquisition period is neces-
sary in order to accurately detect these peaks on the fast
LC-time scale used during HDX experiments. Increasingly
powerful magnetic fields provide one means of lowering
acquisition time, with fields now up to 21 T [46], although
this involves substantial investment. Solving the phase of
the Fourier transform spectrum in absorption mode can
further increase resolving power up to 2-fold beyond the
magnitude mode limit [47-50]. As deuterium-associated
peaks at a given charge state are separated by a constant
mHDX/z, where mHDX is the mass difference between
2H
and 1H minus the mass difference between 13C and 12C,
the acquisition period necessary to resolve deuterium-
associated peaks of a given absolute mass M can be
estimated using:
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where B0 is the effective field strength in absorption
mode, madduct is the ionization adduct mass (typically










is the peak full-width at half height necessary to resolve
Lorentzian-shaped peaks of equal height separated by
mHDX/z with valley between peaks of 50% maximum
height. Thus, in absorption mode at 21 T, <1 sec acquisi-
tion periods are required to resolve deuterium exchange-
associated peaks on digest peptides less than 1 kDa
(Figure 1B). Indeed, for peptides less than 1 kDa, depen-
ding on charge state, absorption mode can also yield
improvements significant enough to make deuterium-
exchange associated peaks resolvable on the more com-
mon 9.4 T FTICR with acquisition periods of <1 sec. On
high performing Orbitrap instruments, resolving powers
in excess of 1 M can be achieved under certain condi-
tions with acquisition times on the time scale of a few
seconds [51], with resolving powers ~240,000 at m/z
400 sufficient to resolve small enough peptides with lessthan one second acquisition times [52]. Thus, with small
enough digest fragments, HDX can be monitored based
on resolved isotopic fine structure on a UPLC-time
scale. However, in monitoring deuterium incorporation
in this fashion, a novel data analysis workflow is neces-
sary to take maximum advantage of this ultrahigh mass
resolution data. As yet, no computational utility for this
workflow exists.
Here, we present QUDeX-MS (quick ultrahigh-reso-
lution hydrogen/deuterium exchange mass spectrometry),
which was developed in order to facilitate the analysis of
isotopic fine structure-resolved HDX MS data. The graph-
ical interface, launched either as a stand-alone program or
within MATLAB, guides users through the process of
interpreting spectra obtained from peptides, proteins, and
other molecules, providing the user with the distribution
of deuterium incorporated as output.
Implementation
For a given charge state of an ion, the distance between
deuterium exchange-associated peaks in an isotopically
resolved distribution is constant (the mass difference
between 2H and 1H divided by charge). Thus, starting
from the monoisotopic m/z, the m/z ? s associated with
deuterium-incorporated forms of the natural abundance
monoisotopic molecule, the ? pseudomonoisotopic peaks?
[43], can be calculated. For example, in the case of human
substance P (C-terminally amidated RPKPQQFFGLM),
the monoisotopic [M + 2H]2+ is found at m/z 674.3713
and the pseudomonoisotopic m/z ? s corresponding to in-
corporation of 1, 2, or 3 deuterium are m/z 674.8745, m/z
675.3776, and m/z 675.8808, respectively (Figure 2A). In
isotopic distributions where fine structure is resolved,
these deuterium-associated peaks are distinct from the
peaks corresponding to the presence of natural abun-
dance isotopes such as the [M + 2H]2+ of substance P
with exactly two 13C at m/z 675.3747, substance P with
exactly one 13C and one deuterium at m/z 675.3762, and
substance P with exact two deuterium at m/z 675.3776
(Figure 2B-C).
QUDeX-MS determines deuterium incorporation by
first finding the percent contribution each pseudomonoi-
sotopic peak has relative to the sum of all the pseudomo-
noisotopic peaks plus the monoisotopic peak (Figure 3).
The average number of deuterium is then determined by
multiplying these percentages by the corresponding num-
ber of deuterium incorporated for each pseudomonoisoto-
pic m/z. For each of these peaks, the relative distribution
of deuterium-associated peak intensities is found, and
from that the mean number of deuteriums incorporated
is calculated [43]. In addition to estimating the number
of deuterium incorporated into the natural abundance
monoisotopic species, this process is repeated for each
natural abundance isotopomer that consists of all the
Figure 2 Traditional versus isotopic fine structure HDX-MS of the [M + 2H]2+ of substance P. A. Isotope distributions of deuterated
peptides (right) are shifted to heavier masses relative to the non-deuterated peptide (left). The monoisotopic isotopomer (green stars) appears
depleted in the deuterated spectrum as it becomes labeled and consequently redistributed throughout the distribution. At typical resolving
powers, natural abundance isotopomers and the isotopomers resulting from HDX that share the same nominal mass are not distinguished. B, C.
In isotopic distributions where fine structure is resolved, deuterium-associated peaks (? pseudomonoisotopic? m/z? s corresponding to incorporation
of 1, 2, or 3 deuterium are thus m/z 674.8745, m/z 675.3776, and m/z 675.8808, respectively) are distinct from the peaks corresponding to the
presence of natural abundance isotopes such as the [M + 2H]2+ of substance P with exactly two 13C, which is present at m/z 675.3747.
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http://www.biomedcentral.com/1471-2105/15/403most abundant naturally occurring stable isotopes (i.e.
14 N, 16O, and 32S) except for an increasing number of
13C (i.e. the isotopomers corresponding to one, two, etc.
13C and no other heavy atoms). A final estimated mean
number of deuterium incorporated is calculated based
on the most abundant of the 13C-associated isotopomer
distributions, which is often the monoisotopic (13C = 0)
species for smaller peptides.
In order to calculate the distribution of deuterium incor-
porated in a given molecule such as a peptide or protein, a
spectrum to be analyzed can be loaded in QUDeX-MS.To demonstrate usage of QUDeX-MS, a spectrum of
deuterated substance P is provided as sample data with
the installation package. Spectra to be analyzed should
be formatted as a two-column (m/z and corresponding
intensity) ASCII file with no headers and standard col-
umn delimiters (i.e. whitespace or commas). Spectra
can be denoised using wavelets [53-55] and baseline
subtracted within QUDeX-MS if necessary using the
included Preprocessing Tool. Adjustments can be made
to slide the m/z alignment within QUDeX-MS, but if
proper assignments are to be made to a reference
Figure 3 Example calculation of deuterium incorporation based on deuterated substance P. The [M + 2H]2+ of substance P is shown on
the left, with each inset showing a zoomed view of the isotopic fine structure detected for each peak that is typically convoluted at lower
resolving powers. QUDeX-MS determines deuterium incorporation by first finding the percent contribution each pseudomonoisotopic peak has
relative to the sum of all the pseudomonoisotopic peaks plus the monoisotopic peak (green star). The average number of deuterium is then
determined by multiplying these percentages by the corresponding number of deuterium incorporated for each peak. As a deuterium nuclei is
approximately 0.003 Da heavier than a 13C nuclei, the pseudomonoisotopic peak (that is, the peak associated with deuterium being the only
heavy isotope in an ion) is seen to be the rightmost peak within a fine isotopic distribution for a given nominal mass. A major contribution to
the intensity of the peaks to the left of the pseudomonoisotopic peak (seen spaced 0.0015m/z apart in this example, as the [M + 2H]2+ of substance
P is shown) are the isotopomers consisting of increasing number of 13C and decreasing number of deuterium.
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well-calibrated beforehand. If necessary, a table of
deuterium-associated m/z ? s (based on a specified mono-
isotopic mass and charge state) can be exported from
QUDeX and used to calibrate spectra in another program
prior to loading into QUDeX.
After loading an experimental spectrum to analyze,
several routes can be chosen for estimating deuterium
incorporation of ion signals in the spectrum (Figure 4).
If the exact elemental formula (or amino acid sequence)
of the ion signal to be analyzed is known, this can be
provided to QUDeX-MS. If the elemental composition
of an ion signal being analyzed is not known, or if the
user does not want to specify it a priori, deuterium in-
corporation can be estimated by detecting isotopically
resolved ion signals in the spectrum within QUDeX-MS,
or by simply specifying a monoisotopic mass from which
to calculate a deuterium-associated m/z distribution.
The precise location of the deuterium-associated peaks
for a given natural abundance isotopomer are then pro-
jected on the spectrum. The m/z alignment (mass cali-
bration) of the spectrum can be adjusted, if necessary,
to better fit with the calculated deuterium-associated
peaks. Once the user is satisfied with the alignment, the
distribution of deuterium incorporation can be deter-
mined from the spectrum by QUDeX-MS. If the elem-
ental formula has been specified, the distribution of
deuterium incorporation can then be used to calculate atheoretical line spectrum, which is projected onto the
loaded spectrum. Calculated theoretical spectra based
on estimated deuterium incorporation can also be
exported as two-column ASCII files for additional
analyses.
For automated processing, spectra can be batched
loaded using a simple configuration file (sample file and
instructions included with QUDeX-MS releases). If the
sequences or formulas are known for spectra being
loaded in batch, this can also be specified in the config-
uration file, and spectra will be processed automatically.
A digest tool is provided with QUDeX-MS that can be
used to determine potential cleavage fragments from a
protein sequence (with or without specifying a protease-
specific cleavage rule) that can be used to assign ions in
a spectrum or set of spectra loaded into QUDeX-MS.
Digest results from QUDeX can be exported and format-
ted (including adding assignments from tandem MS) to
assess sequence coverage using an external tool such as
MSTools [56]. Likewise, the estimated deuterium incor-
poration for analyzed ions in any of the proposed work-
flows can be exported in a report that includes the
estimated mean and standard deviation of incorporation
for each ion and the root-mean-squared error determined
by comparing the experimental mass of detected peaks in
the spectrum with their theoretical values.
For LC-MS experiments, QUDeX-MS will only calculate
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Figure 4 Overview of QUDeX-MS possible workflows. QUDeX-MS can be launched either from MATLAB or as a standalone executable. Once
loaded, a Command Window (top right) and Spectrum View window (bottom) appear. Spectra can be loaded one at a time, with all loaded spectra
managed in the Loaded Spectra listbox. The active spectrum selected in the Loaded Spectra listbox will be displayed in the Spectrum Viewer
window. After loading a spectrum to analyze, several routes can be chosen for estimating deuterium incorporation of ion signals in the spectrum.
An ion can be selected for analysis either by specifying a formula (or peptide sequence), locating a distribution in the spectrum, or specifying a
monoisotopic m/z. Once an ion is loaded, it is displayed in the Loaded Ion listbox, and a deuterium incorporation distribution can be determined
from the selected spectrum by selecting Calculate Exchange. Specific deuterium-associated peaks can be selected from the Command Window to
quickly navigate to a zoomed view of their region of the spectrum in the Spectrum Viewer. If the elemental formula has been specified, the
distribution of deuterium incorporation can then be used to calculate a theoretical spectrum by selecting Model Spectrum. A calculated isotopic
fine structure line spectrum will then be displayed over the loaded spectrum in the Spectrum Viewer window.
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structure-quality spectra (and the fast peptide elution
times necessary in a bottom-up HDX experiment to pre-
vent back-exchange), the number of scans a given peptide
will be in is limited. The user can average scans of ions de-
tected in an LC-MS run and load that as a single spectrum
to calculate deuterium uptake. Given the considerable file
sizes associated with LC-MS runs at this resolving power,
we recommend limiting the m/z range of the resulting
averaged spectrum to only include a particular ion ? s dis-
tribution before loading into QUDeX-MS. Alternatively,
the user can process individual (i.e. not averaged) scans,
including full scans (although we recommend only
loading individual isotopic distributions, if possible),
across an LC-MS run and interpret scan-to-scan vari-
ability in deuterium uptake calculated for a given ion
appropriately.Results and discussion
Calculation of deuterium exchange of a molecule of
known composition
An early step in a typical workflow for HDX MS experi-
ments includes performing tandem mass spectrometry
(MS/MS) on a (non-deuterated) digested protein sample
in order to identify peptides that will be monitored in
later HDX experiments. In this case, where sequence
and modification state of peptides has been determined,
spectra imported into QUDeX-MS can be analyzed by
inputting these known characteristics to determine deu-
terium exchange (Figure 5A). In example spectra pro-
vided with QUDeX-MS, substance P spectra have been
acquired both with and without deuterium exchange.
The default sequence when loading ions by sequence or
formula is set to substance P to help when first learning
how to use QUDeX-MS. The substance P analyzed for
the example spectra was amidated and the appropriate
modification (addition of hydrogen and nitrogen atoms
and removal of one oxygen) is also provided as default.
A specific charge state must also be chosen, which should
correspond to a charge state observed in the mass spec-
trum to be analyzed. By default, QUDeX-MS assumes theuser would like to analyze the protonated form of the in-
put molecule, and thus will adjust the elemental formula
by adding the appropriate number of protons (depending
on charge state). However, this automatic addition of pro-
tons can be disabled, allowing the user to add alternative
adducts (such as Na+ or K+) directly into the elemental
formula. Additional modification to a peptide sequence
can be performed this way as well.
Once specification of the desired ion to be analyzed is
completed, the distribution of m/z values corresponding
to the deuterium-incorporated forms of the natural
abundance monoisotopic molecule are calculated and
projected onto the spectrum (Figure 5B). Now that the
ion to be analyzed is loaded, the deuterium incorpor-
ation can be calculated automatically. In the example of
substance P, we see the mean number of incorporated
deuterium is estimated from the spectrum to be 5.21
based on the distribution of intensities observed from
the deuterium peaks associated with the natural abun-
dance monoisotopic substance P. This was consistent
with the value calculated previously using manual anno-
tation of the spectrum [43].Modeling theoretical spectrum from calculated deuterium
exchange
Included within QUDeX-MS is a method for simulating
an isotopic fine structure line spectrum based on the
estimated deuterium incorporation distribution and the
specified elemental formula. Using the percent contribu-
tions of the pseudomonoisotopic peaks, a set of isotopic
fine structure spectra are simulated [57] using a set of
isotope abundance parameters with a fixed number of
deuterium corresponding to the particular pseudomonoi-
sotopic peak. That is, given that the elemental formula for
amidated substance P is C63H98N18O13S, the [M + 2H]
2+
distribution based on the population of substance P
with no deuterium exchange is modeled using the for-
mula C63H100N18O13S and accepted natural isotope
abundances. In turn, the [M + 2H]2+ distributions for sub-
stance P with exactly 1, 2, and 3 deuterium exchanged
are modeled using the formulae C63DH99N18O13S,
M+4 M+7 13C12H7
13C22H6
Before Loading Formula After Loading FormulaB
A
C
Figure 5 Determining deuterium incorporation from a molecule of known elemental composition and simulating a theoretical
spectrum from calculated deuterium exchange. A. If the exact elemental formula (or amino acid sequence) of the ion signal to be analyzed is
known, this can be provided to QUDeX-MS. If a peptide or protein is being analyzed, in addition to providing an amino acid sequence, the user can
specify posttranslational modifications to the amino acid sequence (input as additions and subtractions of elemental atoms), from which the final
elemental formula is determined. A specific charge state must also be chosen, which should correspond to a charge state observed in the mass
spectrum to be analyzed. B. QUDeX-MS Spectrum Viewer before and after loading pseudomonoisotopic peak locations (appears as black lines when
zoomed out). C. Zoomed in view at two fine isotope distributions corresponding to different nominal masses, with the pseudomonoisotopic peak for
each distribution highlighted in cyan (black lines in B) and calculated theoretical isotopic fine structure based on estimated deuterium incorporation
and the specified elemental formula shown as a line spectrum (vertical black lines in C). In the analysis of the example spectrum of deuterated
substance P, the three major peaks within a fine structure distribution starting from the right moving leftwards are generally the deuterium-associated
peaks corresponding to substance P with exactly 0, 1, or 2 13C (and no other natural abundance heavy isotopes) and decreasing number of deuterium,
as specified in the panel for the M + 7.
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These distributions are then added together, weighted
relative to one another based on their percent contri-
bution estimated from the experimental spectrum. This
composite spectrum is projected onto the experimental
spectrum (Figure 5C). In the analysis of the example
spectrum of deuterated substance P, the three major
peaks in fine structure distributions starting from the
right moving leftwards are generally the deuterium-
associated peaks corresponding to substance P with
exactly 0, 1, or 2 13C (and no other natural abundance
heavy isotopes).
Calculation of deuterium exchange from spectra without
specifying chemical formula a priori
Assuming i) a charge state can be determined from an
ion signal and ii) the monoisotopic peak in a particular
isotopic distribution can be accurately assigned, the m/z ? s
of the deuterium-associated pseudomonoisotopic peaks
can be calculated as these are offset by a constant distance
determined by the charge and the mass of deuterium.
Thus, deuterium incorporation can be estimated for many
molecules without a priori knowledge of formula or the
spectrum of the undeuterated species. The user can dir-
ectly specify a monoisotopic m/z and charge state to
examine, or all isotopically resolved distributions detec-
table in the spectra can be analyzed (Figure 6). This could
be applied to estimating exchange of ions in complex
samples of unidentified material such as natural or-
ganic matter, as well as studying proteins with un-
specified posttranslational modifications or sequence
variations. However, it is important to make sure the
monoisotopic m/z, even if it is not detected, is prop-
erly specified in order to correctly estimate deuterium
exchange.
Identification of digest peptides in a deuterated sample
from a reference protein sequence
In bottom-up HDX experiments studying protein confor-
mation, a proteolytic enzyme is used to digest the protein
after the deuterium exchange reaction has been quenched
by low pH. To help facilitate use of QUDeX-MS in the
context of a typical HDX MS experiment, we have incor-
porated a ? Digest Tool? within the program that allows the
user to specify a protein and digest it in silico. The protein
can be digested using a specified enzyme definition. How-
ever, HDX experiments require enzymes such as pepsin
that are active at low pH but often cleave with broad speci-
ficity, leading to a wide variety of peptides with difficult to
predict cleavage sites. High mass accuracy can be particu-
larly useful in this case to help in the accurate assignment
of peptide fragments [58,59], although some ambiguities
will inevitably remain (such as peptides flanked by the
same amino acid on either side). Thus, the QUDeX-MSDigest Tool also allows determining all possible digest frag-
ments of a certain length. Digest peptides can be imported
directly into the Command Window, edited further to add
modifications, or the digest fragments can be matched to
peaks found in one or all loaded spectra (Figure 7). We
also specifically incorporate the ability to match digest
fragments against a deuterated spectrum in the case where
the monoisotopic peak is not detected. Digest sequences
can be matched against detected isotopic envelopes in a
spectrum (even when they are missing a detectable mono-
isotopic peak) using a combination of (high mass accuracy)
mass defect and information regarding the number of ex-
change sites. This results in the monoisotopic peak being
? assigned? (based on the theoretical mass of the peptide)
even though it is not detectable in the spectrum. In-
cluded with QUDeX-MS is a simulated set of spectra
(with resolving power = 1.5 M) from a pepsin digest
of deuterated SOD1 based on results we previously
observed [9] in order to illustrate how to use the Di-
gest Tool within QUDeX-MS to process fine structure
HDX MS data.
Directions for future development
Currently, QUDeX-MS is specialized for the estimation
of deuterium incorporation in the limit where isotopic
fine structure is well-resolved, which can be challenging
to achieve experimentally. Without well-resolved fine
structure, the ultrahigh mass accuracy of FT-ICR instru-
ments can be useful in increasing the number of unam-
biguous peptide assignments [60]. Indeed, automated
and robust procedures have been developed to leverage
the ability to resolve closely overlapping distributions
(on the order of a few milliDaltons) that can be resolved
on FT-ICR instruments [42]. QUDeX-MS offers the
opportunity to analyze deuterium-exchange peaks dir-
ectly, but requires these peaks be resolved in order to
function accurately. While resolution of deuterium-
associated fine structure is not yet routine, being able
to work interchangeably between the resolving power
regimes where these peaks are resolved and when
they are not would be useful in order to fully utilize
datasets.
Applications already available for analyzing and
managing data from HDX MS experiments already
have many features that enable the visualization and
statistical analysis of HDX MS data. Further incorpor-
ation of features from these programs would help fur-
ther bridging the gap between the already existing
capabilities of traditional HDX MS and isotopic fine
structure HDX MS. Likewise, high mass accuracy
afforded on this instrumentation platform can also aid
in the unambiguous assignment of peptides, including
in the case where only the deuterium-exchanged sample is
analyzed, as described here. Both the high mass accuracy
Figure 6 Determining deuterium incorporation from a molecule of unknown composition. If the elemental composition of an ion signal
being analyzed is not known, or if the user does not want to specify it a priori, deuterium incorporation can be estimated by detecting isotopically
resolved ion signals in the spectrum within QUDeX-MS, or by simply specifying a monoisotopic mass from which to calculate a deuterium-associated
m/z distribution.
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http://www.biomedcentral.com/1471-2105/15/403and ability to resolve isotopic composition could also be
used, combined with HDX data, for the unambiguous
identification of the elemental composition of small mole-
cules, as well as their structural elucidation, particularly in
complex mixtures such as in natural organic matter or
during metabolite profiling. Combining tools used for
elemental composition prediction [61-64] with the ability
for QUDeX-MS to estimate deuterium incorporation
would provide an integrated data analysis environment for
data of this type. Indeed, if elemental composition could
be determined from accurate mass and/or isotopic com-
position, small molecule structure prediction combinedwith HDX data could be used to potentially assign struc-
ture as well.
Conclusions
Isotopic fine structure HDX-MS offers the potential to fur-
ther increase sequence coverage of proteins being analyzed
through high mass accuracy and deconvolution of overlap-
ping ion signals. Many recent advancements in mass spec-
trometers, including the commercialization of the
dynamically harmonized Fourier transform ion cyclotron
resonance cell by Ivan Boldin and Eugene Nikolaev [65],
have further helped researchers to routinely resolve
Figure 7 Digest Tool for automated detection of digest peptides in spectra. A protein sequence can be loaded and digested in silico in
QUDeX-MS, and digest fragments can be matched against ions detected in spectra in order to better automate data analysis in a typical HDX
experiment. Protein sequences can be pasted into the Protein Sequence field, loaded from a fasta file, or retrieved from NCBI using an appropriate
accession. Cleavage specifities for many common proteolytical enzymes are included in QUDeX-MS. Custom cleavage definitions can also be specified,
or all possible peptide fragments can be generated for a specified range of peptide lengths. Digest peptides can be added directly to the Command
Window, further edited individually to add modifications, or can be searched against single or multiple spectra before adding to the Command
Window. Digest peptides detected in loaded spectra are displayed in a results window (bottom panel). The mass error tolerance can be adjusted in this
window, which will update match results automatically. Matching of digest peptides to ions detected in spectra is initially performed based on proper
assignment of the monoisotopic mass. However, digest peptides can also be matched against distributions lacking a detectable monoisotopic peak by
selecting the ? Consider monoisotopic m/z not detectable?? check box. Peptides are then matched to isotopic distributions that fall within m/z bins
associated with deuterium exchange-associated m/z? s within a reasonable distance from the monoisotopic mass (determined by the total number of
deuterium exchangeable sites).
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http://www.biomedcentral.com/1471-2105/15/403isotopic fine structure of peptides. Isotopic fine structure
HDX-MS has also been demonstrated to be useful in the
characterization of molecules in complex mixtures of nat-
ural organic matter [66,67]. As previously demonstrated,however, the data analysis workflow for HDX-MS data with
resolved isotopic fine structure is distinct. QUDeX-MS we
hope will help facilitate the adoption of this technique via
streamlining the data analysis process for researchers.
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